SEP-OrT
Approved For Release 20 k 7,,.,5..",nS."M-MU1,U6-OO788 ROO 1500110001-4
1, (S/NOF'ORN-CL) GENERAL
1.1 The objective of this effort is to investigate a particular aspeCt
of the psychoenergetic phenomena known as remote viewing that has potential
military intelligence application. Coordinate Remote Viewing (CRV),is a
staged technique which utilizes coordinates to facilitate acquisition of a
remote viewing target.
1.2 Major goals are the determination if CRV technology can be successfully
transferred to INSCOM personnel with a corresponding increase in the reliabilily
of a remote viewer.
2. (5/NOFORN-CL) SPECIFIC TASK
2.1. Train army personnel in CRV Stages III and IV.
2.1.1 Initiate training at the highest skill level (CRV Stage) of the
trainee.
2.1.2 Training for each CRV stage will normally be divided into three,
two week working sessions. The Session dates will be MULUally agreed to by SRI
and INSCOM.
2.1.3 After successful completion of CRV Stage III, schedule the trainee
to begin CRV Stage IV.
2.2 Determine the potential of the trainee for further training.
3. (U) SECURITY
Military security requirements in the performance of t@his contract shall be
maintained in accordance with DD Form 254 attached hereto. 'The highest
classification involved in the performance of Lhis contract is SECRET-
NO FOREIGN DISSEMINATION.
4. (S/NOFORN-CL) DELIVERABLES: The contractor will provide the Following.
4.1 State-of-The-Aft CRV training.
4.2 Progress report (2 copies): Written evaluation of trainee progress
at the completion of each two week working session.
4.3 Final Report:
4.3.1 A Final report in 3 copies will he furnished within 30 days
after completion of the CRV stage.
4.3.2 Report will include a summary of the training presented; an
evaluation of the trainee's ability to understand the training; and a summary
of the traince's accomplishments during the training period.
4.3.3 Report should also include an evaluation of the trainee's
fUture remote viewing capabilities, and a recommendation concerning further
training.
           vApprwadEFcmRe,tease 2001/8"t& RDP96-00788ROO1500110001-4
-'ES ANQ _ IL@
NTELLIGENCE SOUR,, wmm--%- M.W1116 I NOT REIIASABLE TO FOMIGN NATIONALS
MFTHQDS. INVQ@VLQ

                                    nrl
DED
Approved For Release 2091/O4&Lt0V6F4DP96-OO788 ROO 1500110001-4
5. (S/NOFORN-CL) POST TRAINING ACCESS: After the completion of' each CRV
training stage personnel involved in the training program will have
reasonable access to INSCOM personnel trained to assist, in fucther eValUation Of'
CRV.
6. (U) SPECIAL REUQIREMENTS
6.1 Use of human subjects
(a) The following definitions are used:
(1) At risk means that Lhe human subject may be @-xposed to the
possibility of harm - physical, biological, psychoiogicai, sociological, or Other
as a consequence of an act or omission that yoes heyond the application
of those established and accepted methods or procedures which are in his
best interests, or that increases ordinary risks of' daily life, including the.
recognized risks inherent in his chosen occupatinn or field of service.
(2) Human subject means any human being who, kno@.,,iingly or unkrvowi'ligly,
is subjected to an act or Omission, whether at riSk or not., the object of
which is to contribute to knowledge tu be gained as a part of ij,@ork to bc
performed under the scope of this contract.
.(b) The contractor, before undertaking to perform any study involv.`-ng
hum.-in Subjects, whether at risk or not, shall inEA1.1-0 that the following mirs." Lmum
conditions are complied with:
(1) The proposed study has beerl reviewed and approved by a commiLtee
meeting the requirements set forth in Chapter 46 of Title 45of the Code of
Federal Regulations.
(2) The number of human S(JbjCCtS Used will be kept to the Mir-IUMUM rWmber
that will reasonably achieve the required results.
(3) The study must be such as to contribute significant-Ily to scientific
knowledge and have reasonahle pro-spects of yielding important results essential
to an, Army research program.
(4) The StUdy will be conducted only by persons possessing the
reqUiSite scientific qualifications. The highest degree Of skill ond care
will be required dUrirlg all Stages Of Study of persons whi,) ckx)duct ot, assist
in the study.
(5)' The 11LIMansubjectuill be informed that at any time dUrifig the
course of his participation lie has the right to revoke his consent and
withdraw from participa@ion without prejudice to himself.
(6) Participation by subjects will be immediately terminat-ed if it
subseqUeritly appears that the risk to the subjects is si@.-,Jnificantly greater
than on 1--i c ipate d at the time review and approval was granted.
IPM T& 6*#'v --e 2 0
  AO O1/O4Mk11f1;AE 96-00788ROO1500110001-4
TrL
- -- - - --@ 1q.01 RELEAsABLE To ri OPMIGH NATIOXALS
DAV,r1iQM5, 2

Approved For Release 2001/04.'. VW-U011HROO1500110001-4
(7) There shall be no greater intrusion into the privacy of the
human subject than is absolutely necessary for the conduct of the study
involved. -Except for the submission of reports and other data required by
this contract, any information obtained about human subjects as a result of
participation shall be held as confidential as the law allows.
(8) The study will be conducted so as to avoid all unnecessary
physical or mental suffering or injury.
(9) No study will be conducted if there is any inherent reason to
believe that death or disabling injury is likely to occur. Sufficient
animal or laboratory.experiments, or other evaluations, must have been completed
to give assurance of acceptable risks prior to the use of human subjects.
(10) The degree of risk to be taken will never exceed that which is
justified by the benefit to the subject and/or the humanitarian importance
of the knowledge to be gained.
(11) A physician will be responsible for the medical care of
subjects.. Even if not the project leader, the physician will have authority
to terminate the.study at any time that he believes death, injury or harm
is likely to result.
(12) Proper preparations will be made, and adequate facilities provided
to protect the subject againsta'll foreseeable possibilities if injury,
disability or death. This includes but is not limited to hospitalization
and medical treatment as may be required. In addition, all apparatus and
instruments necessary to deal with likely emergency situations will be
available.
(13) Human subjects will have no physical or mental conditions, which
will make participation more hazardous for them then it would be for normal
healthy persons, unless such condition is a necessary prerequisite for -the
particular study involved. In any such case, the use of human subjects with
such pre-existing conditions Must have been specifically described and
justified in the scope of the work to be performed under this contract.
(14) The scientifically qualified
and each member of his research team, will
subject's participation at any stage if he
exercise of the good faith, superior skill,
him, that continuation is likely to result
to the human subject.
person conducting the study,
be prepared to terminate the
has reason to believeg in the
     and careful judgement required of
in injury, disability, or death
(c) The contractor, before permitting any person to participate
as a human subject, whether at risk or not, shall insure that the following
minimum conditions are complied with:
(1) Legally effective informed consent will be obtained by adequate
and appropriate methods in accordance with the provisions of this clause.
IV C, I
                   Appi"vwa,fbe,@s 2 @IA-RDP96-00788 ROO 1500110001 -4
2001/04/0
I,NTFLUG@-NICI@ ljoT MEASABLE TO FOREIGN NATIONAts


          Approved For Release 2001 M AAr 11nr_,q7___ -:-.-788RO01 500110001-4
 -LTLWVLv -,
 (2) All consent must be voluntary. It must be the knowing consent
 of' the individual or his legally authorized representative, so situated as
 to be able to exercise Free power of choice without there having been any
 use of force, fraud, deceit, duress, constraint, coercion, or lawful or
 improper inducement. The elements of information necessary to such consent
 include:
 (i) A-fair explanation of the,procoduress to be followed, and their
 purposes, including identification of any procedures which are experimental.
 (ii) -A description of any attendant discomforts or risks reasonably
 to be anticipated.
 (iii) A description of any benefits reasonably to be anticipated.
 (iv) A.disclosure of any appropriate alternative procedures that
 might be advantagious to the subject.
                                      (v) An offer to answer any questions concerninc the procedure.
 9
 (vi) An instruction that the subject is free to revoke his consent
 and to discontinue participation at any time without prejudice to himself
 (d) Exculpatory language through which the subject is made to
 waive, or appear to waive, any of his legal rights, including any release
 from liability for negligence, is prohibited.
 (e) Prior conGent by a subject or his legally authorized
 representative shall be obtained in all cases. Such consent shall be. in
 writing whenever it is reasonably possible to do so. The consent form 0
 may be read to the subject or his legally authorized represontative, but in
 any event he or his legally authorized representative must be given adequate
 opportunity to read it and to ask questions they might have. This consent
 form should then be signed by the subject or his legally authorized
 representative and by a witness not directly involved in the study. Oral
 consent may be used only when it has been specifically dotscribed and
 justified in the scope of the work to be performed under this contract or
 approved in writing by the contracting officer. When so authorized and used,
 oral consent is subject to all the same standards as apply to written consent,
 except that, the signature of the subject or his legally authorized
 representative is not required.
 M Prior to conduct of the study, the contractor shall submit for
 approval to the contracting officer's representative a detailed description
 of the means by which informed consent will be obtained, to include any forms
 to be used. Upon completion of the study, the contractor Will Submit
 to the contracting officer's representative a detailed report demonstrating
 compliance with paragraph (c), to include copies of the written consent if
 such was obtained.
 (g) The contractor shall not undertake to conduct either the clinical
 pharmacology or clinical trails of an investigational drug unless this
 contract contains the clause entitled "Clinical Study of Investigational Drugs."
 'VI~RAWMV,dtt)F.,61'1~-fte~2M4004104102 !-101A14RDP96-LftM8R001W041*"1-4
 INT ELLIGENICE S(), !RGES AND nro=-r - gj,u,_t PMEASABLF, To FOUIGN NATIONALS
 ,METHODS, 1-NYMME-P __91 110-411 1-

 
       Approved For Release 2001/0-11104"1 U 01,15788RO01500110001-4
TWIVI
10C ..m
6.2 DoD Direcive 5240.1-R governing experimentation on human subjects
will be -followed by the contractor. Informed consent of all subjects will
be obtained in writing in accordance with the guidelines issued by the
Department of Health, Education and Welfare. All persons participating
as human subjects, as defined in paragraph 6.1 above shall be known to
possess the abilities and qualities which will be observed and analyzed
during the conduct of Lhis contract.
r#",Jg@se 2001/00MM --MMM-OW88RO01500110001-4
t_0
TTMN. I IT OT M-F,@,SABTM TO V OPXT GN RATT ONALS

  A
         Approved For Release 2001/0 A MR00oa -nn788 ROO 1500110001-4
  W'Am %0,1 %am §
  JUSTIFICATION FOR SOLE SOURCE PROCUREMENT
  1. (5) SRI International is uniquely qualified for this sole source
  procurement by virtue of a combination of experience and performance.
  2. (S/NOFORN). SRI International is a recognized leader in the field of
  psychoenergetics and has performed similar work for other U.S. Government
  agencies over the past few years. Previous work, under DIA contracts
  MDA-908--SI-C-0292 and MDA-908-92-C-0034 has formed a highly meaningful data
  base which,will greatly enhance the value and effectiveness of this new
  contractural effort.
  3. (S) The effort involved for a new contractor to research the same level
  of capability and expertise that SRI currently possesses for this area would
  be too time-consuming and uneconomical to acquire and develop. To acquaint
  a new contractor in this area of expertise, if' he could be found, would
  require several years simply to achieve the present level of expertise and
  competence possessed by SRI Interviational.
  VVARNINGROIJCE: SFNI;JTIVE@ O_Unra%n1%r1
   Appfp f e 20 F_=m!&,-00788 ROO 1 500J jWjA,,jomS
  _,y _70jil N01T 1ELUSABL11